Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase

Journal of Immunology

Volumn 181, Issue 4, 2008, Pages 2330-2337

  Coleman, Arlixer M ^a   Rendon, Beatriz E ^b   Zhao, Ming ^b   Qian, Ming Wei ^b   Bucala, Richard ^c   Xin, Dan ^a   Mitchell, Robert A ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD 74; DOPACHROME TAUTOMERASE; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN C JUN; RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VASCULOTROPIN; DOPACHROME ISOMERASE; IL8 PROTEIN, HUMAN; ISOMERASE; MIF PROTEIN, HUMAN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SUPERNATANT; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LUNG TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELL LINE, TUMOR; HUMANS; INTERLEUKIN-8; INTRAMOLECULAR OXIDOREDUCTASES; LUNG NEOPLASMS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 53149133170     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.4.2330     Document Type: Article

References (48)

1. Greenlee, R. T., T. Murray, S. Bolden, and P. A. Wingo. 2000. Cancer statistics, CA Cancer J. Clin. 50: 7-33.
2. Carney, D. N. 2002. Lung cancer: time to move on from chemotherapy. N. Engl. J. Med. 346: 126-128.
3. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270: 27348-27357.
4. Nor, J. E., J. Christensen, D. J. Mooney, and P. J. Polverini. 1999. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J. Pathol. 154: 375-384.
5. Rot, A. 1992. Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells. Cytokine 4: 347-352.
6. + CXC chemokine-induced angiogenic activity. J. Immunol. 165: 5269-5277.
7. White, E. S., K. R. Flaherty, S. Carskadon, A. Brant, M. D. Iannettoni, J. Yee, M. B. Orringer, and D. A. Arenberg. 2003. Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin. Cancer Res. 9: 853-860.
8. Chen, J. J., P. L. Yao, A. Yuan, T. M. Hong, C. T. Shun, M. L. Kuo, Y. C. Lee, and P. C. Yang. 2003. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin. Cancer Res. 9: 729-737.
9. Arenberg, D. A., M. P. Keane, B. DiGiovine, S. L. Kunkel, S. B. Morris, Y. Y. Xue, M. D. Burdick, M. C. Glass, M. D. Iannettoni, and R. M. Strieter. 1998. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Invest. 102: 465-472.
10. Bloom, B. R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82.
11. Calandra, T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179: 1895-1902.
12. Rendon, B. E., T. Roger, I. Teneng, M. Zhao, Y. Al Abed, T. Calandra, and R. A. Mitchell. 2007. Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J. Biol. Chem. 282: 29910-29918.
13. Howard, B. A., Z. Zheng, M. J. Campa, M. Z. Wang, A. Sharma, E. Haura, J. E. Herndon, M. C. Fitzgerald, G. Bepler, and E. F. Patz, Jr. 2004. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Lung Cancer 46: 313-323.
14. Kettunen, E., S. Anttila, J. K. Seppanen, A. Karjalainen, H. Edgren, I. Lindstrom, R. Salovaara, A. M. Nissen, J. Salo, K. Mattson, et al. 2004. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet. Cytogenet. 149: 98-106.
15. Tomiyasu, M., I. Yoshino, R. Suemitsu, T. Okamoto, and K. Sugimachi. 2002. Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Clin. Cancer Res. 8: 3755-3760.
16. Sun, H. W., J. Bernhagen, R. Bucala, and E. Lolis. 1996. Crystal structure at 2.6-Å resolution of human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA 93: 5191-5196.
17. Leng, L., C. N. Metz, Y. Fang, J. Xu, S. Donnelly, J. Baugh, T. Delohery, Y. Chen, R. A. Mitchell, and R. Bucala. 2003. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197: 1467-1476.
18. Shi, X., L. Leng, T. Wang, W. Wang, X. Du, J. Li, C. McDonald, Z. Chen, J. W. Murphy, E. Lolis, et al. 2006. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25: 595-606.
19. Bernhagen, J., R. Krohn, H. Lue, J. L. Gregory, A. Zernecke, R. R. Koenen, M. Dewor, I. Georgiev, A. Schober, L. Leng, et al. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13: 587-596.
20. Rosengren, E., R. Bucala, P. Aman, L. Jacobsson, G. Odh, C. N. Metz, and H. Rorsman. 1996. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 2: 143-149.
21. Sugimoto, H., M. Taniguchi, A. Nakagawa, I. Tanaka, M. Suzuki, and J. Nishihira. 1999. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 Å resolution. Biochemistry 38: 3268-3279.
22. Xu, X., B. Wang, C. Ye, C. Yao, Y. Lin, X. Huang, Y. Zhang, and S. Wang. 2008. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 261: 147-157.
23. Fan, J., Y. Chen, H. M. Chan, P. K. Tam, and Y. Ren. 2005. Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells. Proc. Natl. Acad. Sci. USA 102: 17751-17756.
24. Ren, Y., H. M. Chan, Z. Li, C. Lin, J. Nicholls, C. F. Chen, P. Y. Lee, V. Lui, M. Bacher, and P. K. Tam. 2004. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 23: 4146-4154.
25. Ren, Y., H. M. Chan, J. Fan, Y. Xie, Y. X. Chen, W. Li, G. P. Jiang, Q. Liu, A. Meinhardt, and P. K. Tam. 2006. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma. Oncogene 25: 3501-3508.
26. White, E. S., S. R. Strom, N. L. Wys, and D. A. Arenberg. 2001. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J. Immunol. 166: 7549-7555.
27. Watanabe, H., T. Shimizu, J. Nishihira, R. Abe, T. Nakayama, M. Taniguchi, H. Sabe, T. Ishibashi, and H. Shimizu. 2004. Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J. Biol. Chem. 279: 1676-1683.
28. Hagemann, T., J. Wilson, H. Kulbe, N. F. Li, D. A. Leinster, K. Charles, F. Klemm, T. Pukrop, C. Binder, and F. R. Balkwill. 2005. Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK. J. Immunol. 175: 1197-1205.
29. Pakozdi, A., M. A. Amin, C. S. Haas, R. J. Martinez, G. K. Haines, III, L. L. Santos, E. F. Morand, J. R. David, and A. E. Koch. 2006. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res. Ther. 8: R132.
30. Mitchell, R. A., H. Liao, J. Chesney, G. Fingerle-Rowson, J. Baugh, J. David, and R. Bucala. 2002. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 99: 345-350.
31. Kim, H. R., M. K. Park, M. L. Cho, C. H. Yoon, S. H. Lee, S. H. Park, L. Leng, R. Bucala, I. Kang, J. Choe, and H. Y. Kim. 2007. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J. Rheumatol. 34: 927-936.
32. Ren, Y., S. Law, X. Huang, P. Y. Lee, M. Bacher, G. Srivastava, and J. Wong. 2005. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann. Surg. 242: 55-63.
33. Ren, Y., H. T. Tsui, R. T. Poon, I. O. Ng, Z. Li, Y. Chen, G. Jiang, C. Lau, W. C. Yu, M. Bacher, and S. T. Fan. 2003. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int. J. Cancer 107: 22-29.
34. Natarajan, R., S. Gupta, B. J. Fisher, S. Ghosh, and A. A. Fowler, III. 2001. Nitric oxide suppresses IL-8 transcription by inhibiting c-Jun N-terminal kinase-induced AP-1 activation. Exp. Cell Res. 266: 203-212.
35. Li, J., S. Kartha, S. Iasvovskaia, A. Tan, R. K. Bhat, J. M. Manaligod, K. Page, A. R. Brasier, and M. B. Hershenson. 2002. Regulation of human airway epithelial cell IL-8 expression by MAP kinases. Am. J. Physiol. 283: L690-L699.
36. Henriquet, C., C. Gougat, A. Combes, G. Lazennec, and M. Mathieu. 2007. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells. Lung Cancer 56: 167-174.
37. Wang, X., Q. Wang, K. L. Ives, and B. M. Evers. 2006. Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin. Cancer Res. 12: 5346-5355.
38. Binsky, I., M. Haran, D. Starlets, Y. Gore, F. Lantner, N. Harpaz, L. Leng, D. M. Goldenberg, L. Shvidel, A. Berrebi, et al. 2007. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc. Natl. Acad. Sci. USA 104: 13408-13413.
39. Ren, Y., S. Law, X. Huang, P. Y. Lee, M. Bacher, G. Srivastava, and J. Wong. 2005. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann. Surg. 242: 55-63.
40. Meyer-Siegler, K. L., K. A. Iczkowski, L. Leng, R. Bucala, and P. L. Vera. 2006. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J. Immunol. 177: 8730-8739.
41. Kleemann, R., A. Hausser, G. Geiger, R. Mischke, A. Burger-Kentischer, O. Flieger, F. J. Johannes, T. Roger, T. Calandra, A. Kapurniotu, et al. 2000. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408: 211-216.
42. Chesney, J., C. Metz, M. Bacher, T. Peng, A. Meinhardt, and R. Bucala. 1999. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol. Med. 5: 181-191.
43. Winner, M., A. C. Koong, B. E. Rendon, W. Zundel, and R. A. Mitchell. 2007. Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Res. 67: 186-193.
44. Winner, M., L. Leng, W. Zundel, and R. A. Mitchell. 2007. Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation. Methods Enzymol. 435: 355-369.
45. Kim, K. S., V. Rajagopal, C. Gonsalves, C. Johnson, and V. K. Kalra. 2006. A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J. Immunol. 177: 7211-7224.
46. Desbaillets, I., A. C. Diserens, N. de Tribolet, M. F. Hamou, and E. G. Van Meir. 1999. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18: 1447-1456.
47. Maxwell, P. J., R. Gallagher, A. Seaton, C. Wilson, P. Scullin, J. Pettigrew, I. J. Stratford, K. J. Williams, P. G. Johnston, and D. J. Waugh. 2007. HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene 26: 7333-7345.
48. Mizukami, Y., W. S. Jo, E. M. Duerr, M. Gala, J. Li, X. Zhang, M. A. Zimmer, O. Iliopoulos, L. R. Zukerberg, Y. Kohgo, et al. 2005. Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells. Nat. Med. 11: 992-997.